Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper.

On 2 December 2021 the results of the annual Pravo-300 law firms’ ranking were announced at an awarding ceremony at the Lotte Hotel in Moscow. Lidings’ top position among the leading legal advisors in Russia once again reflected by the ranking results.

Lidings is pleased to announce Dmitry Kirillov joining the Firm as counsel in Tax and Customs practice.

Lidings Intellectual Property practice lawyers have set a precedent in a dispute concerning patent extension.

Best Lawyers, an international legal directory annually identifying the most prominent lawyers around the world by analyzing their professional skills and achievements during the year, once again lists Lidings’ experts among the best lawyers in Russia.

This year Lidings is celebrating its 15th anniversary in the legal market.

Lawyers of the Lidings Intellectual Property practice have successfully represented interests of the Russian "Miloserdie" (eng.:Mercy) aid service in a trademark protection case. The work was done pro bono.

During a lengthy five-year bankruptcy of the pharmaceutical distributor Grama LLC, the bankruptcy manager challenged transactions with suppliers - large international pharmaceutical companies. Worst-hit was AstraZeneca Pharmaceuticals obliged to return the bankrupt distributor 266 million rubles. Lidings represents the company since 2019.

March 18th 2021 Chambers and Partners Europe has announced the results of its annual research of the leading legal advisors. Lidings is traditionally highly recommended for Dispute Resolution, Corporate and M&A and Life Sciences advice in Russia.  The Firm’s Intellectual Property practice has also entered the ranking this year.

Lidings demonstrates new achievements and takes advanced positions in the rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. Results of the new research published in a special supplement to Kommersant as of March 17, 2021.